Christophe Bourdon, CEO, discusses LEO Pharma's groundbreaking presentations at EADV, delgocitinib's US pending approval, and the company's commitment to addressing chronic hand eczema.
Christophe Bourdon
Advertisement
Articles by Christophe Bourdon
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Updates iPLEDGE REMS with New Modifications for Pregnancy Testing and Prescription Windows
2
Targeting MRGPRX2: Early Human Data for a Novel CSU Approach
3
What Counts as “Short-Term” Systemic Corticosteroids in Atopic Dermatitis, and Why It Matters
4
Precision Medicine Arrives in Atopic Dermatitis: Guiding Systemic Treatment Decisions Through Gene Expression Profiling
5